Titles
- Civil money penalties relating to the ClinicalTrials.gov data bank: guidance for responsible parties, submitters of certain applications and submissions to FDA, and FDA staff1
- Clarence and Mary at the family cottage in Cable, Wisconsin1
- Clarification of orphan designation of drugs and biologics for pediatric subpopulations of common diseases1
- Class II special controls guideline: in vitro diagnostic devices for Bacillus spp. detection : guideline for industry and Food and Drug Administration staff1
- Class III obese patients: is your hospital equipped to address their needs?1
- Class III obese patients: the effect of gait and immobility on patient falls1
- Classification and requirements for laser illuminated projectors (LIPs): (Laser Notice No. 57) : guidance for industry and Food and Drug Administration staff1
- Classification of posterior cervical screw systems: small entity compliance guide : guidance for industry and Food and Drug Administration staff1
- Classification of products as drugs and devices & additional product classification issues: final guidance : guidance for industry and FDA staff1
- Cleaner health care: hospital emissions mitigation1
- Clear liquids may place patients at risk1
- Climate change: information on potential economic effects could help guide federal efforts to reduce fiscal exposure : report to Congressional requesters1
- Clinical decision support for the independent physician practice1
- Clinical decision support software: guidance for industry and Food and Drug Administration staff1
- Clinical documentation: EHR deployment techniques1
- Clinical drug interaction studies with combined oral contraceptives: guidance for industry1
- Clinical drug interaction studies: cytochrome P450 enzyme- and transporter-mediated drug interactions1
- Clinical emergency: are you ready in any setting?1
- Clinical investigations for prostate tissue ablation devices: guidance for industry and Food and Drug Administration staff1
- Clinical labs: studies suggest biopsy specimen misidentification and contamination errors are infrequent : report to the Ranking Member, Committee on Finance, U.S. Senate1